Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil + Carboplatin in Recurrent Gliomas and Brain Metastases
NCT02279992Phase 1Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Mar 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vardenafil in malignant glioma and brain metastasis (BM) (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Concentration of intratumoral carboplatin in tumor tissue and serum samples. Started Mar 2012; status: terminated.
02
Drugs
vardenafil
03
Conditions
malignant gliomabrain metastasis (BM)
Beyond the preview
Go deeper on NCT02279992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279992.